Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety

被引:32
|
作者
Gao, ZG
Joshi, BV
Klutz, AM
Kim, SK
Lee, HW
Kim, HO
Jeong, LS
Jacobson, KA [1 ]
机构
[1] NIDDKD, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA
[2] Ewha Womans Univ, Coll Pharm, Med Chem Lab, Seoul 120750, South Korea
基金
美国国家卫生研究院;
关键词
nucleoside; G protein-coupled receptor; adenylyl cyclase; molecular modeling; radioligand binding;
D O I
10.1016/j.bmcl.2005.10.054
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The highly selective agonists of the A(3) adenosine receptor (AR), Cl-IB-MECA (2-chloro-N-6-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine), and its 4'-thio analogue, were successfully converted into selective antagonists simply by appending a second N-methyl group on the 5'-uronamide position. The 2-chloro-5'-(N,N-dimethyl)uronamido analogues bound to, but did not activate, the human A(3)AR, with K-i values of 29 nM (4'-O) and 15 nM (4'-S), showing > 100-fold selectivity over A(1), A(2A), and A(2B)ARs. Competitive antagonism was demonstrated by Schild analysis. The 2-(dimethylamino)-5'-(N,N-dimethyl)uronamido substitution also retained A3AR selectivity but lowered affinity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:596 / 601
页数:6
相关论文
共 50 条
  • [31] Pharmacological characterisation of novel adenosine A3 receptor antagonists
    Barkan, Kerry
    Lagarias, Panagiotis
    Stampelou, Margarita
    Stamatis, Dimitrios
    Hoare, Sam
    Safitri, Dewi
    Klotz, Karl-Norbert
    Vrontaki, Eleni
    Kolocouris, Antonios
    Ladds, Graham
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Pharmacological characterisation of novel adenosine A3 receptor antagonists
    Kerry Barkan
    Panagiotis Lagarias
    Margarita Stampelou
    Dimitrios Stamatis
    Sam Hoare
    Dewi Safitri
    Karl-Norbert Klotz
    Eleni Vrontaki
    Antonios Kolocouris
    Graham Ladds
    Scientific Reports, 10
  • [33] Recent developments in the field of A3 adenosine receptor antagonists
    Baraldi, PG
    Tabrizi, MA
    Fruttarolo, F
    Bovero, A
    Avitabile, B
    Preti, D
    Romagnoli, R
    Merighi, S
    Gessi, S
    Varani, K
    Borea, PA
    DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) : 315 - 329
  • [34] QSAR Analysis of Human Adenosine A3 Receptor Antagonists
    Qiao Kang
    Zeng Ling-Xiao
    Jin Hong-Wei
    Liu Zhen-Ming
    Zhang Liang-Ren
    ACTA PHYSICO-CHIMICA SINICA, 2012, 28 (06) : 1509 - 1519
  • [35] Synthesis of adenosine analogues with indole moiety as human adenosine A3 receptor ligands
    Xia, Yan
    Zheng, Xiliang
    Wang, Erkang
    Li, Dongfeng
    Hou, Ruibin
    Wang, Jin
    ROYAL SOCIETY OPEN SCIENCE, 2018, 5 (02):
  • [36] N6,5′-disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor
    van Tilburg, EW
    Künzel, JVD
    de Groote, M
    Vollinga, RC
    Lorenzen, A
    IJzerman, AP
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (08) : 1393 - 1400
  • [37] Structural determinants of efficacy at A3 adenosine receptors:: modification of the ribose moiety
    Gao, ZG
    Jeong, LS
    Moon, HR
    Kim, HO
    Choi, WJ
    Shin, DH
    Elhalem, E
    Comin, MJ
    Melman, N
    Mamedova, L
    Gross, AS
    Rodriguez, JB
    Jacobson, KA
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (05) : 893 - 901
  • [38] Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A3 adenosine receptor
    Volpini, R
    Costanzi, S
    Lambertucci, C
    Vittori, S
    Klotz, KN
    Lorenzen, A
    Cristalli, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (14) : 1931 - 1934
  • [39] The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor
    DeNinno, MP
    Masamune, H
    Chenard, LK
    DiRico, KJ
    Eller, C
    Etienne, JB
    Tickner, JE
    Kennedy, SP
    Knight, DR
    Kong, J
    Oleynek, JJ
    Tracey, WR
    Hill, RJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (09) : 2525 - 2527
  • [40] Discovery of next generation A3 adenosine receptor selective agonists for treatment of chronic neuropathic pain
    Tosh, Dilip K.
    Paoletta, Silvia
    Ford, Amanda
    Janes, Kali
    Salvemini, Daniela
    Jacobson, Kenneth A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247